- Home
- FULC vs TSAT Comparison
FULC vs TSAT Comparison
Compare FULC & TSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FULC
- TSAT
- Stock Information
- Founded
- FULC 2015
- TSAT 1969
- Country
- FULC United States
- TSAT Canada
- Employees
- FULC N/A
- TSAT N/A
- Industry
- FULC Biotechnology: Pharmaceutical Preparations
- TSAT Metal Fabrications
- Sector
- FULC Health Care
- TSAT Industrials
- Exchange
- FULC Nasdaq
- TSAT Nasdaq
- Market Cap
- FULC 468.1M
- TSAT 515.2M
- IPO Year
- FULC 2019
- TSAT 1996
- Fundamental
- Price
- FULC $11.74
- TSAT $24.88
- Analyst Decision
- FULC Buy
- TSAT
- Analyst Count
- FULC 7
- TSAT 0
- Target Price
- FULC $10.43
- TSAT N/A
- AVG Volume (30 Days)
- FULC 922.1K
- TSAT 101.3K
- Earning Date
- FULC 10-29-2025
- TSAT 11-04-2025
- Dividend Yield
- FULC N/A
- TSAT N/A
- EPS Growth
- FULC N/A
- TSAT N/A
- EPS
- FULC N/A
- TSAT N/A
- Revenue
- FULC N/A
- TSAT $324,440,552.00
- Revenue This Year
- FULC N/A
- TSAT N/A
- Revenue Next Year
- FULC N/A
- TSAT N/A
- P/E Ratio
- FULC N/A
- TSAT N/A
- Revenue Growth
- FULC 2752.05
- TSAT N/A
- 52 Week Low
- FULC $2.32
- TSAT $10.11
- 52 Week High
- FULC $12.14
- TSAT $36.85
- Technical
- Relative Strength Index (RSI)
- FULC 72.74
- TSAT 39.16
- Support Level
- FULC $7.51
- TSAT $23.10
- Resistance Level
- FULC $9.05
- TSAT $25.75
- Average True Range (ATR)
- FULC 0.80
- TSAT 1.74
- MACD
- FULC 0.27
- TSAT -0.45
- Stochastic Oscillator
- FULC 89.63
- TSAT 23.32
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
About TSAT Telesat Corporation
Telesat Corp is a satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.